Literature DB >> 10925305

Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils.

S Eglite1, K Plüss, C A Dahinden.   

Abstract

Anaphylatoxin derived from the fifth complement component (C5a) in the presence of IL-3 induces continuous leukotriene C4 generation and IL-4 and IL-13 expression in human basophils for a period of 16-18 h. This indicates that the G protein-coupled C5a receptor (C5aR) can induce long-lasting cellular responses. Using anti-N-terminal C5aR Abs, C-terminal C5a hexapeptide analogs, and pertussis toxin, we demonstrate that the putative activation site of the C5aR is both necessary and sufficient for these late cellular responses. Furthermore, continuous pertussis toxin-sensitive G protein-coupled receptor activation and receptor-ligand interaction is ongoing and required during the entire period of product release. However, the late basophil responses have a more stringent requirement for optimal receptor activation. Leukotriene C4 generation appears to be influenced mostly by the way the receptor is activated, because the most active hexapeptide is a superagonist for this response. By contrast, C5adesarg, lacking the C-terminal arginine, induces minimal lipid mediator formation but is fully active to induce IL-4 production and is even a superagonist for IL-13 release. Nevertheless, IL-4/IL-13 synthesis in response to C5adesarg could be blocked by both C-terminal antagonistic peptide as well as anti-N-terminal C5aR Abs, indicating only minor differences of ligand-receptor interactions between C5a and C5adesarg. Taken together, our data demonstrate that long-lasting and continuous signaling occurs through a limited activation domain of the C5aR, which can differentially promote separate basophil functions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925305     DOI: 10.4049/jimmunol.165.4.2183

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Molecular basis for downregulation of C5a-mediated inflammation by IgG1 immune complexes in allergy and asthma.

Authors:  Manoj Kumar Pandey
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

Review 2.  Understanding the roles of basophils: breaking dawn.

Authors:  Booki Min; Melissa A Brown; Graham Legros
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

3.  Cys-leukotrienes promote fibrosis in a mouse model of eosinophil-mediated respiratory inflammation.

Authors:  Sergei I Ochkur; Cheryl A Protheroe; Wen Li; Dana C Colbert; Katie R Zellner; Hua-Hao Shen; Andrew D Luster; Charles G Irvin; James J Lee; Nancy A Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

Review 4.  A complex role for complement in allergic asthma.

Authors:  Xun Zhang; Jörg Köhl
Journal:  Expert Rev Clin Immunol       Date:  2010-03       Impact factor: 4.473

5.  The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.

Authors:  Anne-Marie Scola; Adrian Higginbottom; Lynda J Partridge; Robert C Reid; Trent Woodruff; Stephen M Taylor; David P Fairlie; Peter N Monk
Journal:  J Biol Chem       Date:  2006-12-11       Impact factor: 5.157

6.  C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay.

Authors:  Edimara S Reis; Hui Chen; Georgia Sfyroera; Peter N Monk; Jörg Köhl; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2012-10-05       Impact factor: 5.422

Review 7.  Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.

Authors:  Hydar Ali
Journal:  Immunol Lett       Date:  2009-11-04       Impact factor: 3.685

8.  Investigation of C5a receptor gene 450 C/T polymorphism in Turkish patients with familial Mediterranean fever.

Authors:  Eren Erken; Ramazan Gunesacar; Huseyin T E Ozer
Journal:  Mol Biol Rep       Date:  2009-08-06       Impact factor: 2.316

9.  A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.

Authors:  Jörg Köhl; Ralf Baelder; Ian P Lewkowich; Manoj K Pandey; Heiko Hawlisch; Lihua Wang; Jennifer Best; Nancy S Herman; Alyssa A Sproles; Jörg Zwirner; Jeffrey A Whitsett; Craig Gerard; Georgia Sfyroera; John D Lambris; Marsha Wills-Karp
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

10.  New developments in C5a receptor signaling.

Authors:  J Vidya Sarma; Peter A Ward
Journal:  Cell Health Cytoskelet       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.